HealthEquity, Inc. $HQY Shares Sold by Summit Creek Advisors LLC

Summit Creek Advisors LLC reduced its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 4.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 184,841 shares of the company’s stock after selling 7,684 shares during the quarter. HealthEquity accounts for about 2.7% of Summit Creek Advisors LLC’s holdings, making the stock its 6th biggest position. Summit Creek Advisors LLC’s holdings in HealthEquity were worth $16,933,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the business. Cullen Frost Bankers Inc. grew its holdings in shares of HealthEquity by 41.8% during the fourth quarter. Cullen Frost Bankers Inc. now owns 2,818 shares of the company’s stock valued at $258,000 after buying an additional 830 shares during the last quarter. Handelsbanken Fonder AB grew its holdings in shares of HealthEquity by 14.4% during the fourth quarter. Handelsbanken Fonder AB now owns 24,616 shares of the company’s stock valued at $2,255,000 after buying an additional 3,100 shares during the last quarter. ProShare Advisors LLC grew its holdings in shares of HealthEquity by 4.3% during the fourth quarter. ProShare Advisors LLC now owns 19,058 shares of the company’s stock valued at $1,746,000 after buying an additional 783 shares during the last quarter. Radnor Capital Management LLC grew its holdings in shares of HealthEquity by 130.2% during the fourth quarter. Radnor Capital Management LLC now owns 14,366 shares of the company’s stock valued at $1,268,000 after buying an additional 8,126 shares during the last quarter. Finally, Abacus Wealth Partners LLC acquired a new position in shares of HealthEquity during the fourth quarter valued at about $269,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

HQY has been the subject of a number of analyst reports. Royal Bank Of Canada reduced their price objective on shares of HealthEquity from $110.00 to $100.00 and set an “outperform” rating for the company in a report on Wednesday, March 18th. JPMorgan Chase & Co. dropped their price target on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 18th. UBS Group set a $110.00 price target on shares of HealthEquity in a research report on Tuesday, February 17th. Deutsche Bank Aktiengesellschaft raised their price target on shares of HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research report on Thursday, March 19th. Finally, BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and raised their price target for the company from $85.00 to $105.00 in a research report on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, HealthEquity presently has an average rating of “Moderate Buy” and a consensus target price of $111.79.

HealthEquity Stock Up 3.4%

HQY opened at $87.55 on Thursday. The firm has a market capitalization of $7.34 billion, a P/E ratio of 35.59, a PEG ratio of 1.54 and a beta of 0.19. The company has a debt-to-equity ratio of 0.45, a current ratio of 3.27 and a quick ratio of 3.27. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $116.65. The company’s 50-day moving average is $82.13 and its 200 day moving average is $87.03.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, March 17th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.90 by $0.05. The business had revenue of $334.59 million for the quarter, compared to analyst estimates of $332.48 million. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The business’s quarterly revenue was up 7.3% on a year-over-year basis. Research analysts expect that HealthEquity, Inc. will post 3.84 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.